Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension
Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
The study will evaluate the effectiveness and safety of an investigational drug-ganaxolone -
on partial seizure frequency in adults with epilepsy taking a maximum of 3 antiepileptic
medications (AEDs).